Subacromial Impingement Syndrome Recruiting Phase 2 Trials for Methylprednisolone (DB00959)

IndicationStatusPhase
DBCOND0036420 (Subacromial Impingement Syndrome)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03913702Subacromial Methylprednisolone Versus Ketorolac for Shoulder ImpingementTreatment